Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › (bis)urea and (bis)thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders

(bis)urea and (bis)thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders

US Patent 9708255 · Granted Jul 18, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

KDM4B inhibitors for the treatment of inflammatory diseases and disorders2023
Compositions and methods for therapy of prostate cancer using drug combinations 2021
Aminotriazole-based KDM1A inhibitors as epigenetic modulators2018
Histone deacetylase inhibitors and uses thereof2018
Small molecules as epigenetic modulators of lysine-specific demethylase 1 and me2016
Small molecules as epigenetic modulators of lysine-specific demethylase 1 and me2016
Cyclic peptide inhibitors of lysine-specific demethylase 12015
Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-s2012
Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-s2012
6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor in grapefruit2000